A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study

SIMPLE SUMMARY: Soft tissue sarcomas (STS) are an uncommon and heterogeneous group of tumors, with scarce options for treatment in advanced cases. There is no consensus regarding which is the best treatment sequence for these patients. Although trabectedin is an approved drug for STS treatment, afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Trufero, Javier, De Sande-González, Luis Miguel, Luna, Pablo, Martin-Broto, Javier, Álvarez, Rosa, Marquina, Gloria, Diaz-Beveridge, Roberto, Poveda, Andrés, Cano, Juana María, Cruz-Jurado, Josefina, López Pousa, Antonio, Vaz Salgado, María Angeles, Valverde-Morales, Claudia M., Sevilla, Isabel, Martínez-García, Jerónimo, Rubio-Casadevall, Jordi, De Juan, Ana, Carrasco, Juan Antonio, Moura, David S, Gurruchaga-Sotes, Ibon, Gutiérrez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917652/
https://www.ncbi.nlm.nih.gov/pubmed/33672857
http://dx.doi.org/10.3390/cancers13040792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917652/
https://www.ncbi.nlm.nih.gov/pubmed/33672857
http://dx.doi.org/10.3390/cancers13040792

Ejemplares similares